We report the findings from a clinical trial in which a group of patients clinically diagnosed with probable Alzheimer's disease (AD) were discriminated from an age-matched group of healthy volunteers (HVs) with statistical significance (P<.001). The results from 20 patients with AD and 20 HVs were obtained by a Fluorescent Ligand Eye Scanning (FLES) technique that measures a fluorescent signature specific to an exogenous ligand bound to amyloid-β in the lens of the eye. Sensitivity and specificity of 85% and 95%, respectively, have been achieved in predicting clinical diagnosis. Additionally, amyloid brain imaging using florbetapir F18 positron emission tomography shows significant correlation with the results obtained in the eye. Results of the study demonstrate the safety of the FLES system.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10852881PMC
http://dx.doi.org/10.1177/1533317513520214DOI Listing

Publication Analysis

Top Keywords

alzheimer's disease
8
detection amyloid
4
amyloid signature
4
signature lens
4
lens correlation
4
correlation brain
4
brain aid
4
aid diagnosis
4
diagnosis alzheimer's
4
disease report
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!